FI107917B - Förfarande för framställning av terapeutiskt användbara 2-oxo-3-pyrrolinylkarboxamidoetylbensensulfonylurea- och tioureaderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara 2-oxo-3-pyrrolinylkarboxamidoetylbensensulfonylurea- och tioureaderivat Download PDF

Info

Publication number
FI107917B
FI107917B FI946136A FI946136A FI107917B FI 107917 B FI107917 B FI 107917B FI 946136 A FI946136 A FI 946136A FI 946136 A FI946136 A FI 946136A FI 107917 B FI107917 B FI 107917B
Authority
FI
Finland
Prior art keywords
ethyl
formula
oxo
urea
methyl
Prior art date
Application number
FI946136A
Other languages
English (en)
Finnish (fi)
Other versions
FI946136A0 (sv
FI946136A (sv
Inventor
Joachim Kaiser
Dieter Mania
Heinrich Englert
Jens Hartung
Heinz Goegelein
Uwe Gerlach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI946136A0 publication Critical patent/FI946136A0/sv
Publication of FI946136A publication Critical patent/FI946136A/sv
Application granted granted Critical
Publication of FI107917B publication Critical patent/FI107917B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D521/00Heterocyclic compounds containing unspecified hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Claims (4)

1. Förfarande för framställning av terapeutiskt användbara 2-oxo-3-pyrrolinylkarboxamidoetylbensensulfon-5 ylurea- och -tioureaderivat med formeln H H H R ( 1 ) - H\yH - S02 Vs^rXCH2"CH2 - N \/R 3
10. R(2)^^ 0 (!) där R (1) är C1_g —alkyl; R (2) är F, Cl, Br, I eller C^g-alkoxi;
15 E är syre eller svavel; och R {3) är en grupp med formeln
20 V^R(5) 0 • · • · · ··1 ·· · : 1.· där R (4) och R (5) betecknar C^-alkyl, *ί2ί kännetecknat därav, att : 25 (a) för framställning av substituerade bensensul- ··· ··· fonyltioureaderivat med formeln (Ib) , • · · · ··· • · · • · 1 H H CH2-CH2 _ H (3) ·:··: R ( 1 ) - NX/N - S02 Y 30. ji T ...2 ^ o s R ( 2 ) • · • · · :3: (ib) ··· · • · 2 • · · 3 *. . 35 omsätts en bensensulfonamid II eller ett dess salt III • · · • ·· • « 25 107917 γη c H ^ H CHj—CH. H
5 R(2)^^ ° 1(2Γ^ 0 (II) (III) varvid M är en alkalimetall- eller jordalkalimetallkatjon, 10 med ett R (1) -substituerat isocyanat med formeln R (1) - N = C = S (IV) eller 15 (b) för framställning av substituerade bensensul- fonylureaderivat med formeln (Ia), H H H MO - »w« - so2^^.r - *w«(i) Ϊ JOT ¥
0 R (2) 0 !:;:= da) • « • 25 omsätts ett bensensulfonyltioureaderivat med formeln (Ib) ··· med ett oxidationsmedel. ··· ·
2. Förfarande enligt patentkrav 1, kanne- • » · t e c k n a t därav, att man framställer en förening med . formeln (I), där *^1 30 R (1) är C^.g-alkyl; och ···* R (2) är F, Cl eller C^.g-alkoxi.
3. Förfarande enligt patentkrav 1, k ä n n e - .***· t e c k n a t därav, att man framställer en förening med ··· • formeln (I), där ·· ' 1 ' • · • ·· • · • ·- · · 26 107917 R (1) är C^-alkyl; och R (2) är F eller Cl.
4. Förfarande enligt patentkrav 1, kanne-t e c k n a t därav, att man framställer en förening med 5 formeln (I), där R (1) är -alkyl; och R (2) är C-^-alkoxi. • · • « · • I» • · · • « 9 • 9 9 · • ♦ · » · · • · · « · · • 9 « ···· ··· • · « • · · • · ··1 • · ··· • · • · • « · 9 ··« • « • · ··· ·· • · • · · • 9 9 9 9 9 99 9 9
FI946136A 1993-12-30 1994-12-28 Förfarande för framställning av terapeutiskt användbara 2-oxo-3-pyrrolinylkarboxamidoetylbensensulfonylurea- och tioureaderivat FI107917B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4344957 1993-12-30
DE4344957A DE4344957A1 (de) 1993-12-30 1993-12-30 Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Herstellungsverfahren und Verwendungsmöglichkeiten pharmazeutischer Präparate auf Basis dieser Verbindungen

Publications (3)

Publication Number Publication Date
FI946136A0 FI946136A0 (sv) 1994-12-28
FI946136A FI946136A (sv) 1995-07-01
FI107917B true FI107917B (sv) 2001-10-31

Family

ID=6506518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946136A FI107917B (sv) 1993-12-30 1994-12-28 Förfarande för framställning av terapeutiskt användbara 2-oxo-3-pyrrolinylkarboxamidoetylbensensulfonylurea- och tioureaderivat

Country Status (19)

Country Link
EP (1) EP0661264B1 (sv)
JP (1) JP3718248B2 (sv)
KR (1) KR100370307B1 (sv)
CN (1) CN1052976C (sv)
AT (1) ATE194594T1 (sv)
AU (1) AU679136B2 (sv)
CA (1) CA2138930C (sv)
DE (2) DE4344957A1 (sv)
DK (1) DK0661264T3 (sv)
ES (1) ES2149234T3 (sv)
FI (1) FI107917B (sv)
GR (1) GR3034513T3 (sv)
HU (1) HU217122B (sv)
IL (1) IL112172A (sv)
NO (1) NO302750B1 (sv)
NZ (1) NZ270265A (sv)
PT (1) PT661264E (sv)
TW (1) TW436481B (sv)
ZA (1) ZA9410380B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503136A1 (de) * 1995-02-01 1996-08-08 Hoechst Ag Substituierte Thiophenylsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
TR199901816T2 (xx) * 1997-01-29 1999-11-22 Pfizer Inc S�lfonil �re t�revleri, bunlar�n interl�kin-1 aktivitesinin kontrol�nde kullan�mlar�.
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
CA2853466A1 (en) * 2011-10-26 2013-05-02 Emily A. Stein Agents, methods, and devices for affecting nerve function
CN103420891B (zh) * 2013-06-09 2015-10-21 南通市华峰化工有限责任公司 Ⅱ型糖尿病药物格列美脲中间体苯磺胺三光气的合成方法
CN103601661B (zh) * 2013-09-22 2015-10-21 江苏德峰药业有限公司 Ⅱ型糖尿病药物格列美脲三光气的合成方法
CN103508932B (zh) * 2013-09-22 2015-06-10 江苏德峰药业有限公司 糖尿病药物格列美脲的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE2951135A1 (de) * 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Also Published As

Publication number Publication date
CA2138930C (en) 2006-01-17
FI946136A0 (sv) 1994-12-28
KR950017939A (ko) 1995-07-22
CN1109872A (zh) 1995-10-11
ZA9410380B (en) 1995-08-29
ATE194594T1 (de) 2000-07-15
ES2149234T3 (es) 2000-11-01
HUT70830A (en) 1995-11-28
AU8178994A (en) 1995-07-06
NO302750B1 (no) 1998-04-20
CA2138930A1 (en) 1995-07-01
EP0661264B1 (de) 2000-07-12
GR3034513T3 (en) 2000-12-29
CN1052976C (zh) 2000-05-31
JP3718248B2 (ja) 2005-11-24
EP0661264A1 (de) 1995-07-05
PT661264E (pt) 2000-12-29
IL112172A0 (en) 1995-03-15
NO945083D0 (no) 1994-12-29
HU9403803D0 (en) 1995-02-28
DE4344957A1 (de) 1995-07-06
DK0661264T3 (da) 2000-10-23
NZ270265A (en) 1995-10-26
IL112172A (en) 1999-03-12
FI946136A (sv) 1995-07-01
TW436481B (en) 2001-05-28
HU217122B (hu) 1999-11-29
NO945083L (no) 1995-07-03
KR100370307B1 (ko) 2003-10-11
JPH07206807A (ja) 1995-08-08
AU679136B2 (en) 1997-06-19
DE59409440D1 (de) 2000-08-17

Similar Documents

Publication Publication Date Title
FI114152B (sv) Förfarande för framställning av terapeutiskt användbara substituerade bensensulfonylurinämnen och tiourinämnen
EP1339668A2 (en) Bisubstituted carbocyclic cyclophilin binding compounds and theirus
FI107917B (sv) Förfarande för framställning av terapeutiskt användbara 2-oxo-3-pyrrolinylkarboxamidoetylbensensulfonylurea- och tioureaderivat
JP4242936B2 (ja) 3−アミドクロマニルスルホニル(チオ)尿素、それらの製法、それらの使用およびそれらを含有する医薬製剤
FI107152B (sv) Förfarande för framställning av nya terapeutiskt användbara aminosubstituerade bensensulfonyltioureaderivat
KR100446565B1 (ko) 치환된벤젠설포닐티오우레아,이의제조방법및이를포함하는약제학적조성물
RU2198872C2 (ru) Замещенные бензолсульфонилмочевины и -тиомочевины, способ их получения, содержащая их фармацевтическая композиция и способ ее получения
CZ2001169A3 (en) 2,5-Substituted benzenesulfonyl ureas and -thioureas, process of their preparation, their use as well as pharmaceutical preparations in which they are comprised
FI120392B (sv) Substituerade bensensulfonylurea och -tioureaföreningar, förfarande för framställning av dessa, deras användning för framställning av farmaceutiska preparat och läkemedel, som innehåller dessa
US5631275A (en) Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
KR100449192B1 (ko) 치환된티오펜설포닐우레아및-티오우레아,이의제조방법및이를함유하는약제학적조성물
SK160296A3 (en) Substituted chromanylsulphonyl(thio)ureas, preparation method thereof, their use in pharmaceutical compositions as well as drugs containing them
MXPA97008783A (en) 3-amido-cromanilsulfonil (tio) ureas, procedure for its preparation, its employment and pharmaceutical preparations that contain it

Legal Events

Date Code Title Description
MM Patent lapsed